Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the mammalian cell fermentation technology market?

In recent times, the market size of mammalian cell fermentation technology has experienced a significant expansion. Anticipated to surge from $51.29 billion in 2024 to $57.48 billion in 2025, the market will manifest a compound annual growth rate (CAGR) of 12.1%. Factors contributing to this robust growth during the historic phase include amplified demand for biologics and biosimilars, a heightened emphasis on personalized medicine, an upsurge in the production of biopharmaceuticals, and increased need for scalable and efficient cell culture techniques.

What will be the mammalian cell fermentation technology market size in the future?

The market size of the mammalian cell fermentation technology is anticipated to experience substantial growth in the coming years. The expected size is projected to reach $89.54 billion by 2029, with a compound annual growth rate (CAGR) of 11.7%. The growth during this prediction period could be due to factors like the increased prevalence of chronic diseases, more capital investment from multinational companies, a rising occurrence of chronic diseases, greater adoption of sophisticated bioprocessing methods, increased funding in R&D for new recombinant proteins, and an escalating demand for cancer treatments. Key trends during this period are expected to include advancements in cell culture technology, developments in bioreactor design, the evolution of next-generation bioprocessing technologies, the combination of multi-omics strategies, and automation driven by technology.

Get your mammalian cell fermentation technology market report here!

https://www.thebusinessresearchcompany.com/report/mammalian-cell-fermentation-technology-global-market-report

What main drivers are fueling expansion in the mammalian cell fermentation technology market?

The bacterial cell fermentation technology market is predicted to accelerate in response to the burgeoning demand for biologics. Derived from living organisms or their components, these medical products are commonly used to combat diseases such as cancer, infectious diseases, and autoimmune disorders. The surge in demand for biologics can be attributed to advancements in biotechnology, their efficacy in managing widespread chronic diseases such as cancer and autoimmune disorders, regulatory approvals, and increased investment in research and development. Mammalian cell fermentation technology plays a fundamental role in efficiently manufacturing complex biologics, thereby catering to the growing need for personalized and targeted remedies. Attributes such as scalability, versatility, and the capacity to produce high-quality proteins stimulate innovation in the biopharmaceutical sector. For instance, the National Library of Medicine, a US-based medical library, announced in February 2024 that the FDA approved 55 new drugs in 2023, comprising 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This represents a 50% increase from the 37 approvals in 2022. Therefore, the escalating demand for biologics is contributing to the expansion of the bacterial cell fermentation technology market.

What key areas define the segmentation of the global mammalian cell fermentation technology market?

The mammalian cell fermentation technology market covered in this report is segmented –

1) By Type: Chinese Hamster Ovary Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types

2) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Other Applications

3) By End-Use: Biopharmaceutical Companies, Contract Research Organizations And Contract Development and Manufacturing Organizations, Academic And Research Institutes

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp

Who are the dominant players expanding their reach in the mammalian cell fermentation technology market?

Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

What emerging trends are influencing the growth of the mammalian cell fermentation technology market?

Key players in the mammalian cell fermentation technology market are concentrating their efforts on creating novel technologies such as mammalian cell culture to solidify their market presence. Mammalian cell culture is pivotal in numerous sectors like biomanufacturing, research, and regenerative medicine due to its ability to produce therapeutic proteins, vaccines, and functional cell or tissue analogues. For example, Syntegon, a German biotechnology firm, introduced its innovative Modular Bioprocessing Platform (MBP) at Achema 2024 in June 2024. It was designed to address the major issues in biopharmaceutical production. The platform provides a flexible, fully-integrated, and automatic solution for a wide range of applications including microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The modular construction of MBP allows for faster turnaround times and lower expenses without compromising on functionality and quality, conforming to the “made in Germany” standard. Moreover, its prefabricated cleanroom design positions all supplementary technology outside the cleanroom, boosting productivity and streamlining maintenance.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16473

Which regions are emerging as leaders in the mammalian cell fermentation technology market?

North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cell and Gene Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Stem Cell Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report

Cell Culture Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: